Abstract
1. The distribution of indomethacin in fat and protein fractions of colostrum and mature milk as well as its milk to plasma drug concentration ratio (M/P ratio) were determined in vitro. 2. The extent of plasma protein binding of indomethacin (5-20 microg ml(-1)) was > or = 99.6%. The protein binding of indomethacin in colostrum was 46.0% at pH 7.4. The lower protein content of mature milk compared with colostrum was associated with a significant decrease in the extent of drug protein binding (46 +/- 1.93 to 35 +/- 1.0 s.e. mean). Protein binding was also decreased significantly in 8% fat mature milk (20.3 +/- 2.4 s.e mean) but was constant over the pH range 7.4 to 6.8. 3. About 40% of indomethacin added to milk was associated with the fatty layer. The indomethacin M/P ratio determined by equilibrium dialysis was less than 0.01. Hence the maximum infant daily dose was estimated to be 0.006 mg kg(-1). 4. Our results indicate that indomethacin transfers to milk by simple diffusion according to its physicochemical properties, and that treatment with indomethacin is not a contraindication to breast feeding.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Atkinson H. C., Begg E. J. Relationship between human milk lipid-ultrafiltrate and octanol-water partition coefficients. J Pharm Sci. 1988 Sep;77(9):796–798. doi: 10.1002/jps.2600770916. [DOI] [PubMed] [Google Scholar]
- Bianchetti G., Monin P., Marchal F., Dubruc C., Boutroy M. J., Morselli P. L., Vert P. Pharmacokinetics of indomethacin in the premature infant. Dev Pharmacol Ther. 1980;1(2-3):111–124. [PubMed] [Google Scholar]
- Eeg-Olofsson O., Malmros I., Elwin C. E., Steen B. Convulsions in a breast-fed infant after maternal indomethacin. Lancet. 1978 Jul 22;2(8082):215–215. doi: 10.1016/s0140-6736(78)91962-1. [DOI] [PubMed] [Google Scholar]
- Fleishaker J. C., Desai N., McNamara P. J. Factors affecting the milk-to-plasma drug concentration ratio in lactating women: physical interactions with protein and fat. J Pharm Sci. 1987 Mar;76(3):189–193. doi: 10.1002/jps.2600760302. [DOI] [PubMed] [Google Scholar]
- Helleberg L. Clinical Pharmacokinetics of indomethacin. Clin Pharmacokinet. 1981 Jul-Aug;6(4):245–258. doi: 10.2165/00003088-198106040-00001. [DOI] [PubMed] [Google Scholar]
- Hultmark D., Borg K. O., Elofsson R., Palmer L. Interaction between salicylic acid and indomethacin in binding to human serum albumin. Acta Pharm Suec. 1975;12(3):259–276. [PubMed] [Google Scholar]
- Lebedevs T. H., Wojnar-Horton R. E., Yapp P., Roberts M. J., Dusci L. J., Hackett L. P., Ilett K. F. Excretion of indomethacin in breast milk. Br J Clin Pharmacol. 1991 Dec;32(6):751–754. [PMC free article] [PubMed] [Google Scholar]
- Lucas A., Gibbs J. A., Lyster R. L., Baum J. D. Creamatocrit: simple clinical technique for estimating fat concentration and energy value of human milk. Br Med J. 1978 Apr 22;1(6119):1018–1020. doi: 10.1136/bmj.1.6119.1018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Macheras P. E., Koupparis M. A., Antimisiaris S. G. Drug binding and solubility in milk. Pharm Res. 1990 May;7(5):537–541. doi: 10.1023/a:1015881103340. [DOI] [PubMed] [Google Scholar]
- Mason R. W., McQueen E. G. Protein binding of indomethacin: binding of indomethacin to human plasma albumin and its displacement from binding by ibuprofen, phenylbutazone and salicylate, in vitro. Pharmacology. 1974;12(1):12–19. doi: 10.1159/000136516. [DOI] [PubMed] [Google Scholar]
- Needs C. J., Brooks P. M. Antirheumatic medication during lactation. Br J Rheumatol. 1985 Aug;24(3):291–297. doi: 10.1093/rheumatology/24.3.291. [DOI] [PubMed] [Google Scholar]
- Wilson J. T. Determinants and consequences of drug excretion in breast milk. Drug Metab Rev. 1983;14(4):619–652. doi: 10.3109/03602538308991402. [DOI] [PubMed] [Google Scholar]